Analyst Research

Report Title Price
Trading Report for (CI). A detailed report, including free correlated market analysis, and updates.
Provider: Stock Traders Daily
$58.00
Buy
Thomson Reuters Stock Report - CIGNA CORPORATION (CI-N)
Provider: Thomson Reuters Stock Report
$25.00
Buy
Cigna Corporation (CI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Provider: GlobalData
$250.00
Buy
The Investment Rate - a measure of investment demand.
Provider: Stock Traders Daily
$495.00
Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research

CIGNA Corporation Raises FY 2012 Earnings Guidance


Thursday, 3 May 2012 06:00am EDT 

CIGNA Corporation announced that it now estimates fiscal 2012 consolidated adjusted income from operations to be in the range of $1.52-$1.63 billion, or $5.20 to $5.55 per share. This outlook reflects expected continued solid execution of our strategy resulting in strong organic growth, expected increase in medical services utilization during 2012, and contributions from the acquisition of HealthSpring. 

Latest Developments for Cigna Corp

Latest Key Developments in Insurance

Company Quote

Cigna Corp
(CI.N)
67.96
0.36 +0.53%
22 May 2013